Chief Financial Officer Of Precigen Inc. (PGEN) Has Bought 24,500 Of The Company’s Shares

0
6
BEPC Stock
BEPC Stock

The stock of Precigen Inc. (NASDAQ:PGEN) increased by $0.05 on Wednesday to $1.99, up 2.62 percent. The last five days have seen an average of 1,017,951 shares of common stock traded. 2 times new highs were reached in the current year, with a fall of -$1.6950. The average number of shares traded over the last 20 days was 843,793, while the average volume over the last 50 days totaled 851,509.

PGEN stock appreciated 13.45% since last month. On 11/09/22, the company’s shares reached a one-month low of $1.4400. The stock touched a high of $4.20 on 01/04/22, after rallying from a low of $1.12 in 52 weeks. The price of PGEN stock has declined by -47.71% or -$1.6950 this year, reaching a new high 2 times. Still, the stock price is down -52.60% from the 52-week high.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


Insider Transactions

PGEN stock investors should be aware that Precigen Inc. (PGEN) stock had its last reported insider trading activity 92 days ago on Aug 23. On Aug 23, Chief Financial Officer Thomasian Harry Jr. acquired 24,500 shares at $2.09 each. This transaction resulted in the insider spending $51,205. On Aug 11, KINDLER JEFFREY B sold 50,000 shares at a price of US$2.30. After the transaction, the insider now owns 214,411 shares. SVP, IP Affairs Perez Jeffrey Thomas had earlier sold 14,778 shares on May 17 for $1.28 a share. The transaction was completed for $18,916.

Valuation Metrics

Beta for the stock is 1.87. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 7.72, the price-to-book (PB) ratio of 2.73.

Financial Health

For the three months ended September 29, Precigen Inc.’s quick ratio was 1.60, while its current ratio was 1.60, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 59.50% percent. Based on annual data, it had gross profit of $45.49 million and revenue of $103.87 million.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. PGEN’s return on assets (ROA) during the last 12 months has been 8.00%. There was a -27.30% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 26.80%.

Earnings Surprise

According to Precigen Inc.’s quarterly financial report for the quarter that ended September 29, it had $62.26 million in cash and short-term investments. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $16.72 million, while revenues fell by -28.95% to $2.91 million. It was predicted that Precigen Inc.’s quarterly earnings would be $0.44, but it ended up being $0.02. EBITDA was -$4.55 million for the quarter. At the end of Precigen Inc.’s most recent quarter ended September 29, its liabilities totaled 116.71 million, while its total debt was $91.05 million. Equity owned by shareholders amounts to $208.15 million.

Technical Picture

Here’s a quick look at Precigen Inc.’s (PGEN) price momentum from a technical perspective. As of 22 November, the RSI 9-day stood at 65.43%, suggesting the stock is Neutral, with a 53.16% historical volatility rate.

The stochastic %K and %D were 83.93% and 82.56% respectively, while the average true range (ATR) was 0.1455. Based on the 14-day stochastic reading of 88.46%, the RSI (14) reading is 59.28%. On the 9-day MACD Oscillator, the stock is at 0.0478, and the 14-day reading is at 0.1544.

Analyst Ratings

In its analyst report released on November 18, 2022, Cantor Fitzgerald began covering Precigen Inc. (NASDAQ: PGEN). The stock was rated as an Overweight by the brokerage firm. Analysts have assigned Precigen Inc. (PGEN) an Buy rating. PGEN is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.

What is PGEN’s price target for the next 12 months?

The current consensus forecast for the stock is between $4.20 and $14.00, with a median target price of $6.50. In analyzing these forecasts, the average price target given by analysts for Precigen Inc. (PGEN) is $7.80.

LEAVE A REPLY

Please enter your comment!
Please enter your name here